BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2022
View Archived Issues
OR6A2 is a therapeutic target for atherosclerosis, researchers unveil
Read More
Novel ester prodrugs of E-selectin antagonists with improved PK properties
Read More
New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical
Read More
New PROTACs targeting androgen receptors sythesized at Sichuan Haisco Pharmaceutical
Read More
Abbisko Therapeutics discovers EGFR inhibtors
Read More
Shenzhen Salubris Pharmaceuticals patents ADAM-TS 5 inhibitors
Read More
Vitalixir presents new antidiabetic polypeptides
Read More
Researchers identify COPA as a prognostic marker and therapeutic target in cervical cancer
Read More
Acute intermittent porphyria treatment targets recombinant PBGD protein to the liver
Read More
DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity
Read More
Novel CDK9 inhibitor inhibits osteosarcoma in patient-derived orthotopic xenografts
Read More
Loss of miR-15a/miR-16-1 contributes to CLL development
Read More
Ethris to advance mRNA-based therapeutics for respiratory diseases
Read More
Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology
Read More
Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study
Read More
Drug cocktail is step up for leg regeneration
Read More